Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • APP vs MRNA✓SelectedUSD · MRNAAPP vs MRNA performance historyLatest closeAs of-8.11%11/20
Stock and ETF performance explorer

APP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+264.7%
MRNA return
-27.3%
Excess return
+292.0%
Maximum drawdown
-90.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-8.1%-2.2%-5.9%-7.9%
7D-14.9%-12.7%-2.2%-13.8%
30D+30.0%-20.7%+50.7%+32.4%
3M+12.8%+46.3%-33.5%+8.3%
6M-27.8%+305.2%-333.0%-44.4%
YTD-48.3%+561.2%-609.6%-65.1%
1Y-33.1%+772.1%-805.2%-57.8%
3Y+781.7%+147.0%+634.8%+571.8%
All+264.7%-27.3%+292.0%+260.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling